Skip to main content
Clinical Trials/CTRI/2020/03/023825
CTRI/2020/03/023825Active, not recruitingPhase 3

Effect of Liposomal Vitamin C on Immune function in healthy children (4-12 Years)

SSV Phytopharmaceuticals0 sites26 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Active, not recruiting
Sponsor
Enrollment
26

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age 4-12 years
  • Written informed consent by parents

Exclusion Criteria

  • 13 years or older, younger than 4 years
  • participation in a clinical study during past 30 days
  • intake of antimicrobial, antiviral, immunosuppressive substances, salicylic medicaments (like Aspirin)
  • surgical intervention 3 months Prior to inclusion or planned intervention during the observation period
  • Any respiratory or metabolic disorder

Investigators

Sponsor
SSV Phytopharmaceuticals

Similar Trials

Effect of Liposomal Vitamin C on Immunity... | Clinical Trial